Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy

Warsaw, Masovian Voivodeship 02-781

0 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumors, Cervical Cancer, Cholangiocarcinoma, Crohn's Disease, Follicular Lymphoma, HER2-positive Advanced Solid Tumors, Hematologic Neoplasms, Leiomyosarcoma, Non Small Cell Lung Cancer, Ovarian Cancer, Refractory Follicular Lymphoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. — Running, not enrolling
• Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) — Running, not enrolling
• A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms — Completed
• Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305) — Stopped early